Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
193
datasets available to search
ShareScore release 0.9.0
Dataset results
193 results for “CD20”
Optimizing HBV Management During Anti-CD20 Antibodies
ClinicalTrials.gov study NCT03155984. IPD Sharing: NO. Countries: 1. Publications: 0.
A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT07189325. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone Lymphoma
ClinicalTrials.gov study NCT07355699. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5
ClinicalTrials.gov study NCT06284122. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04802590. IPD Sharing: NO. Countries: 3. Publications: 0.
A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBC
ClinicalTrials.gov study NCT02772822. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of JMT601 in Participants With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06725524. IPD Sharing: NO. Countries: 1. Publications: 0.
A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects
ClinicalTrials.gov study NCT01205737. IPD Sharing: Not stated. Countries: 10. Publications: 0.
A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT05424822. IPD Sharing: YES. Countries: 8. Publications: 0.
Dose Escalation and Expansion Study of CPO107 for Patients with Advanced CD20-positive Non-Hodgkins Lymphoma
ClinicalTrials.gov study NCT04853329. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04918940. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03456466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies
ClinicalTrials.gov study NCT02924402. IPD Sharing: NO. Countries: 4. Publications: 0.
A Feasibility and Safety Study of Universal Dual Specificity CD19 and CD20 or CD22 CAR-T Cell Immunotherapy for Relapsed or Refractory Leukemia and Lymphoma
ClinicalTrials.gov study NCT03398967. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Two Anti-CD20 Regimens for Fibrillary Glomerulonephritis
ClinicalTrials.gov study NCT06680349. IPD Sharing: NO. Countries: 1. Publications: 0.
Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT04425824. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy
ClinicalTrials.gov study NCT04640818. IPD Sharing: NO. Countries: 1. Publications: 0.
Pilot Study of Anti-CD20-CAR-engineered T Cells in Patients With Chemotherapy Resistant or Refractory CD20+ Lymphoma
ClinicalTrials.gov study NCT02965157. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients
ClinicalTrials.gov study NCT05040906. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20
ClinicalTrials.gov study NCT03605238. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.